Bioadaptives (BDPT) FCF Margin (2016 - 2026)

Bioadaptives has disclosed FCF Margin across 9 years of filings, most recently posting 1538.61% for Q1 2026.

• FCF Margin for Q1 2026 came in at 1538.61%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 2113.98% (up 4325521.0% YoY), and the FY2025 annual result was 2921.68%, down 95217.0% from the prior year.
• FCF Margin came in at 1538.61% for Q1 2026 at Bioadaptives, down from 1494.47% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 343.35% in Q1 2024 to a low of 7623.11% in Q2 2024.
• The 5-year median for FCF Margin is 1516.54% (2025), against an average of 1983.64%.
• Across the five-year window, FCF Margin tumbled 519186 bps in 2024 and soared 417539 bps in 2025, its largest moves.
• Bioadaptives' FCF Margin stood at 690.36% in 2022, then plunged by 84 bps to 1267.82% in 2023, then sank by 501 bps to 7623.11% in 2024, then soared by 80 bps to 1494.47% in 2025, then retreated by 3 bps to 1538.61% in 2026.
• The last three FCF Margin figures came in at 1538.61% (Q1 2026), 1494.47% (Q4 2025), and 3266.6% (Q3 2025), per Business Quant data.